A1.
2011–2014 | 2015–2017 | |||
---|---|---|---|---|
# Reported | % Tested | # Reported | % Tested | |
Candida albicans | 7,994 | 21.8 | 10,376 | 24.3 |
Candida glabrata | 3,454 | 32.9 | 4,649 | 34.8 |
Candida parapsilosis | 1,627 | 34.2 | 1,995 | 38.9 |
This table is limited to central line-associated bloodstream infections (CLABSIs) and surgical site infections (SSIs). Data from inpatient rehabilitation facilities (IRFs) and long-term acute care hospitals (LTACHs) are excluded from this table. Due to NHSN definition changes over time and the low volume of Candida reported for certain HAIs, catheter-associated urinary tract infections (CAUTIs), possible ventilator-associated pneumonias (PVAPs), and ventilator-associated pneumonias (VAPs) are excluded from this table.